Kaplan Fox & Kilsheimer LLP Announces Proposed Class Action Settlement on Behalf of all Persons and Entities that Purchased the Common Stock of Spectrum Pharmaceuticals, Inc.NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that the United States District Court for the Southern District of New York has approved the following announcement of a proposed class action settlement that would benefit all persons and entities that purchased the Common Stock of Spectrum Pharmaceuticals, Inc.:
